Stratified analysis based on different peripheral blood tumor markers, HER2 and PDL1 expression in tissue biopsies also showed that the RSA model outperformed both the clinical and radiomics model in clinical prediction (Figure 2I–K). Here, ERBB2 is linked to neoplasm.